Skip to main content

Table 1 Crude and adjusted ORs of age and FIT variables for association with ACN in the derivation (Phase I) cohort (Seminal model: C-Statistic = 0.846; Brier Score = 0.115; Hosmer-Lemeshow p-value = 0.796)

From: Prediction of advanced colonic neoplasm in symptomatic patients: a scoring system to prioritize colonoscopy (COLONOFIT study)

X

Control group (non-AA, non-CRC)

AA+CRC

OR (Crude)

OR (Adjusted)

Age group (years)

  ≤ 40

66 (9.48%)

1 (0.58%)

Ref.

Ref.

 40–50

98 (14.1%)

6 (3.51%)

3.61 [0.58;94.9]

4.62 [0.49;43.6]

 50–60

157 (22.6%)

34 (19.9%)

12.5 [2.63;299]

17.9 [2.25;142.4]

  > 60

375 (53.9%)

130 (76.0%)

20.0 [4.42;469]

21.54 [2.8;165.6]

MAXFIT (out of 3 samples)

  ≤ 11

508 (73.0%)

33 (19.3%)

Ref.

Ref.

  > 11

188 (27.0%)

138 (80.7%)

11.2 [7.49;17.3]

2.31 [0.99;5.38]

NSAMPLES> 4

 0

441 (63.4%)

24 (14.0%)

Ref.

Ref.

 1

110 (15.8%)

18 (10.5%)

3.01 [1.55;5.74]

2.98 [1.54;5.8]

 2

71 (10.2%)

18 (10.5%)

4.65 [2.37;9.01]

4.49 [2.3;8.8]

 3

74 (10.6%)

111 (64.9%)

27.2 [16.7;46.0]

28.1 [16.8;46.9]

  1. MAXFIT: maximum f-Hb value; NSAMPLES > 4: Number of samples with FIT > 4 μg Hb/g faeces